About AlphaTON Capital Corp.
https://www.portagebiotech.comAlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON). AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately US $100 million.
CEO
Brittany Kaiser
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-08-15 | Reverse | 1:20 |
| 2020-06-04 | Reverse | 1:100 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : B-
Price Target
About AlphaTON Capital Corp.
https://www.portagebiotech.comAlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON). AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately US $100 million.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $0 | $1.47M | $-1.88M | 0% | $-1.44 | $-1.47M |
| Q3-2025 | $0 | $1.47M ▼ | $-1.88M ▼ | 0% | $-1.44 ▼ | $-1.47M ▲ |
| Q2-2025 | $0 | $1.6M ▼ | $-1.36M ▲ | 0% | $-1.26 ▲ | $-1.6M ▲ |
| Q1-2025 | $0 | $2.84M ▼ | $-1.66M ▲ | 0% | $-1.58 ▼ | $-2.84M ▲ |
| Q4-2024 | $0 | $3.25M | $-24.89M | 0% | $-1.26 | $-24.89M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $1.67M | $2.23M | $3.05M | $-123K |
| Q3-2025 | $1.67M ▼ | $2.23M ▼ | $3.05M ▲ | $-123K ▼ |
| Q2-2025 | $1.76M ▼ | $2.71M ▼ | $2.01M ▼ | $1.4M ▼ |
| Q1-2025 | $3.33M ▼ | $5.24M ▼ | $3.43M ▼ | $2.51M ▼ |
| Q4-2024 | $5.03M | $7.78M | $4.45M | $4.02M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-1.88M | $-1.11K | $0 | $1.06M ▲ | $0 ▲ | $-1.11K |
| Q3-2025 | $-1.88M ▼ | $-1.11K ▲ | $0 | $1.06K ▲ | $-1.76K ▲ | $-1.11K ▲ |
| Q2-2025 | $-1.36M ▲ | $-1.56M ▲ | $0 | $-10K ▼ | $-1.57M ▲ | $-1.56M ▲ |
| Q1-2025 | $-1.66M ▲ | $-1.69M ▲ | $0 ▼ | $-8K ▼ | $-1.69M ▼ | $-1.69M ▲ |
| Q4-2024 | $-24.89M | $-3.21M | $2.81M | $45.52K | $-313K | $-3.21M |
CEO
Brittany Kaiser
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-08-15 | Reverse | 1:20 |
| 2020-06-04 | Reverse | 1:100 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : B-